Showing 91 - 100 of 5,053
Persistent link: https://www.econbiz.de/10005015131
This article contrasts trends in addressing work productivity in severe mental illnesses (SMI) such as schizophrenia and in affective disorders. Citations from searches of 8 reference databases were reviewed. The negative impact of SMI on employment is indisputable, as is the fact that people...
Persistent link: https://www.econbiz.de/10005590129
Objective: To investigate the impact of epilepsy in Italy on healthcare resources, producing an average cost per patient per year of follow-up. Design and setting: The Episcreen Project is a multicentre longitudinal Italian observational study; its methodology, organisational network and case...
Persistent link: https://www.econbiz.de/10005590270
Crohn's disease is a chronic inflammatory bowel disease of unknown aetiology which affects around 35 000 people in the UK (population 56.8 million). The potential for onset in early adult life, disease chronicity and a need for hospitalisation and surgery mean that the disease can be associated...
Persistent link: https://www.econbiz.de/10005590309
Objective: To estimate the cost of lost work days due to ischaemic heart disease (IHD), and the cost of this reduced productivity using reduction in household income. Design and setting: Using 2 years of nationally representative observational data, this study examined the effect on household...
Persistent link: https://www.econbiz.de/10005590333
The effectiveness of drug treatment in clinical practice is considerably lower than the efficacy shown in controlled studies. The lower effectiveness in practice presumably leads to lower cost effectiveness of drug treatment in real-life situations compared with that demonstrated by studies...
Persistent link: https://www.econbiz.de/10005590347
With limited financial resources available, it is now becoming more acceptable to evaluate medical innovations in terms of incremental economic value. The purpose of this paper is to provide an overview of enteroviral meningitis and to summarise the economic literature to identify relevant costs...
Persistent link: https://www.econbiz.de/10005590406
It has been suggested that the annual direct costs for irritable bowel syndrome (IBS) are now around $US41 billion in the 8 most industrialised countries. This paper reviews the data on calculations of direct costs. The true economic burden is unclear, as there are insufficient data on indirect...
Persistent link: https://www.econbiz.de/10005590450
Persistent link: https://www.econbiz.de/10005615787
Willingness to pay models have shown the theoretical relationships between the contingent valuation, cost of illness and the avertive behaviour approaches. In this paper, field survey data are used to compare the relationships between these three approaches and to demonstrate that contingent...
Persistent link: https://www.econbiz.de/10005547552